FIELD: medicine, cell engineering.
SUBSTANCE: claimed method includes providing of histocompability antigen-free cells by hybridization of somatic cells of different animal species; cultivation thereof on medium of specific composition. Then cells are seeded with seeding coefficient of 1:3, monolayer is obtained which is held at 37°C. Cells are removed from substrate by Versen solution and 0.25 % trypsin solution in ratio of 9:1. Obtained cells are administered to patient.
EFFECT: method for removing of histoincompability barrier without using immunodepressants and other additional components.
4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| INTERSPECIFIC HYBRID CELL LINE OF SHEEP KIDNEY (Ovis aries) WITH RABBIT LYMPHOCYTES FOR CULTIVATION OF INFECTIVE RHINOTRACHEITIS VIRUS AND CATTLE VIRAL DIARRHEA VIRUS | 2005 |
|
RU2306334C2 |
| HUMAN MELANOMA CELL LINE mel Ksen, USED FOR ANTITUMOUR VACCINES MANUFACTURE | 2008 |
|
RU2392316C1 |
| HUMAN MELANOMA CELL LINE mel Z USED FOR MAKING ANTI-TUMOUR VACCINES | 2008 |
|
RU2390556C1 |
| CYTOGENETIC METHOD FOR ESTIMATING FUNCTIONAL ACTIVITY OF T- LYMPHOCYTES IN PATIENТ'S BLOOD | 1995 |
|
RU2112984C1 |
| METHOD OF ASSAY OF ACTIVATED LYMPHOCYTES IN BLOOD | 1992 |
|
RU2080597C1 |
| METHOD OF DETERMINATION OF ACTIVATED T-LYMPHOCYTES IN BLOOD | 0 |
|
SU1024839A1 |
| METHOD OF ASSAY OF THE ACTIVATED T-LYMPHOCYTES IN HUMAN ORGANISM | 1992 |
|
RU2080598C1 |
| STRAIN OF INTERSPECIES HYBRID SHEEP CELLS (OVIS ARIES) WITH RABBIT BETA-CELLS AS INSULIN PRODUCER | 2005 |
|
RU2293116C1 |
| PEPTIDE POSSESSING IMMUNOGEROPROTECTIVE EFFECT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301074C1 |
| STRAIN OF HYBRID CULTURED MOUSE CELLS MUS MUSCULUS USED FOR PREPARING OF MONOCLONAL ANTIBODIES TO THE GROUP-SPECIFIC ANTIGEN IN HUMAN ERYTHROCYTES | 1986 |
|
RU1352941C |
